Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $9.68B | $9.84B | -1.62% |
Cost of Revenue | $2.31B | $2.53B | -8.80% |
Net Income | $1.63B | $1.16B | +40.57% |
EPS (Basic) | $11.21 | $8.02 | +39.78% |
EPS (Diluted) | $11.18 | $7.97 | +40.28% |
SG&A Expense | $2.4B | $2.55B | -5.73% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $28.05B | $26.84B | +4.49% |
Current Assets | $7.46B | $6.86B | +8.71% |
Total Liabilities | $11.33B | $12.05B | -5.91% |
Current Liabilities | $5.53B | $3.43B | +60.99% |
Long-Term Debt | $6.3B | $6.79B | -7.25% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $2.88B | $1.55B | +85.85% |
Investing Cash Flow | $-799.2M | $-4.1B | +80.51% |
Financing Cash Flow | $-683.5M | $149.3M | -557.80% |
Share Buybacks | $0 | $0 | — |
D&A | $673.2M | $494.8M | +36.05% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Net Margin | 16.9% | — | — |
ROA | 5.8% | — | — |
Current Ratio | $1.349 | — | — |
Other companies in Biotechnology